Exploring the Australian Stroke and Heart Accelerator’s High Potential Research Portfolio

The MTPConnect Podcast

The Australian Stroke and Heart Research Accelerator, established through MTPConnect’s Targeted Translation Research Accelerator for cardiovascular disease and diabetes on behalf the Medical Research Future Fund, is a research centre with a bold vision to deliver new health outcomes in coronary artery disease, heart failure and stroke.

Through clinical impact and entrepreneurship, an Australian wide network of academics, institutions, and industry partners are driving a high potential research portfolio and an education and training program with a commercialisation focus.

We talk to stroke and heart research experts Professor Geoffrey Donnan AO and Professor Jason Kovacic about the Centre’s groundbreaking work covering various pipeline projects, including BiVACOR’s Total Artificial Heart, advanced tele-robotic thrombectomy technologies and a national research clinical trials register, all aimed at improving health outcomes for Australians.
Joining host Caroline Duell is Lauren Kelly, MTPConnect’s Senior Director, Targeted Translation Research Accelerator (TTRA) for diabetes and cardiovascular disease.

Capitoli

1. Exploring the Australian Stroke and Heart Accelerator’s High Potential Research Portfolio (00:00:00)

2. Announcement (00:00:02)

3. Introduction by Caroline Duell (00:00:35)

4. Introduction to the Australian Stroke and Heart Research Accelerator (ASHRA) (00:01:35)

5. Focus on unmet need in stroke and CVD (00:02:10)

6. Partnership with BiVACOR (00:09:53)

7. World first remote technology (00:14:32)

8. Taking the hospital to the patient with stroke management (00:17:42)

9. Join Us - National Register Facilitating Clinical Trials (00:19:48)

10. Supporting projects through training (00:24:16)

11. Future of ASHRA Research (00:26:01)